Royalty Pharma plc

RPRX

$60.69

Name : Royalty Pharma plc

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $35,068,833,792.00

EPSttm : 1.86

Royalty Pharma plc

$60.69

1.68%

$1.04

RPRX — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

2.56

Margin Of Safety %

-20

Put/Call OI Ratio

0.14

EPS Next Q Diff

0.22

EPS Last/This Y

3.54

EPS This/Next Y

0.41

Price

61.73

Target Price

65.29

Analyst Recom

1.5

Performance Q

17.78

Upside

-33.0%

Beta

0.43

Ticker: RPRX

22 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-07-21	RPRX	58.44	0.16	0.06	8252
2026-07-22	RPRX	58.7	0.16	1.20	8272
2026-07-23	RPRX	59.04	0.17	0.00	8291
2026-07-24	RPRX	58.83	0.17	0.02	8313
2026-07-27	RPRX	58.73	0.17	13.67	8315
2026-07-28	RPRX	59.99	0.17	0.13	8356
2026-07-29	RPRX	59.14	0.17	0.00	8357
2026-07-30	RPRX	59.02	0.16	0.11	9129
2026-07-31	RPRX	58.42	0.16	0.22	9136
2026-08-03	RPRX	57.19	0.16	0.06	9140
2026-08-04	RPRX	57.45	0.16	0.06	9082
2026-08-05	RPRX	57.87	0.16	0.10	9197
2026-08-06	RPRX	57.24	0.16	0.23	9182
2026-08-07	RPRX	56.79	0.16	0.17	9182
2026-08-10	RPRX	57.97	0.16	0.01	9213
2026-08-11	RPRX	57.8	0.15	0.00	9917
2026-08-12	RPRX	59.2	0.15	0.01	9925
2026-08-13	RPRX	58.56	0.15	0.01	9914
2026-08-14	RPRX	58.6	0.14	0.01	10205
2026-08-17	RPRX	59.46	0.14	0.01	10152
2026-08-18	RPRX	59.69	0.14	0.03	10310
2026-08-19	RPRX	61.73	0.14	0.04	10273
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

22 items 1 of 1

19 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-07-21	RPRX	58.44	11.6	-165.0	5.23
2026-07-22	RPRX	58.71	11.6	-182.7	5.23
2026-07-23	RPRX	59.04	11.6	-181.8	5.23
2026-07-24	RPRX	58.82	11.6	-192.1	5.23
2026-07-27	RPRX	58.71	11.6	-190.6	5.23
2026-07-28	RPRX	59.99	11.6	-162.9	5.23
2026-07-29	RPRX	59.17	11.6	-203.9	5.23
2026-07-30	RPRX	59.03	11.6	-190.3	5.23
2026-07-31	RPRX	58.44	11.6	-199.7	5.23
2026-08-03	RPRX	57.17	11.6	-213.2	5.23
2026-08-04	RPRX	57.17	11.6	-213.2	5.23
2026-08-05	RPRX	57.74	11.6	-182.5	5.23
2026-08-06	RPRX	57.23	11.6	-198.4	5.23
2026-08-07	RPRX	56.79	11.6	-211.0	5.23
2026-08-13	RPRX	58.55	-0.2	-152.6	5.33
2026-08-14	RPRX	58.60	-0.2	-136.0	5.33
2026-08-17	RPRX	59.47	-0.2	-116.9	5.33
2026-08-18	RPRX	59.69	-0.2	-131.7	5.33
2026-08-19	RPRX	61.73	-0.2	-89.8	5.33
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

19 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-07-21	RPRX	-2.45	-0.13	3.00
2026-07-22	RPRX	-2.45	-0.13	3.00
2026-07-23	RPRX	-2.45	-0.13	3.00
2026-07-24	RPRX	-2.27	-0.13	3.00
2026-07-27	RPRX	-2.21	-0.00	2.92
2026-07-28	RPRX	-2.21	-0.00	2.92
2026-07-29	RPRX	-2.21	-0.00	2.92
2026-07-30	RPRX	-2.21	-0.00	2.92
2026-07-31	RPRX	-2.21	-0.00	2.92
2026-08-03	RPRX	-2.16	0.09	2.92
2026-08-04	RPRX	-2.16	0.09	2.92
2026-08-05	RPRX	-1.52	0.09	2.92
2026-08-06	RPRX	-1.52	0.09	2.92
2026-08-07	RPRX	-1.52	0.09	2.92
2026-08-10	RPRX	-1.52	-0.29	2.91
2026-08-11	RPRX	-1.52	-0.29	2.91
2026-08-12	RPRX	-1.52	-0.29	2.56
2026-08-13	RPRX	-1.52	-0.29	2.56
2026-08-14	RPRX	-1.52	-0.29	2.56
2026-08-17	RPRX	-1.52	-0.82	2.56
2026-08-18	RPRX	-1.55	-0.82	2.56
2026-08-19	RPRX	-1.55	-0.82	2.56
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

1.32

Avg. EPS Est. Current Quarter

1.17

Avg. EPS Est. Next Quarter

1.54

Insider Transactions

-1.55

Institutional Transactions

-0.82

Beta

0.43

Average Sales Estimate Current Quarter

685

Average Sales Estimate Next Quarter

730

Fair Value

49.41

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

-2.1

Max Drawdown 5-Year %

-42

Target Price

65.29

P/E

32.86

Forward P/E

10.76

PEG

1.05

P/S

P/B

4.03

P/Free Cash Flow

11.79

EPS

1.88

Average EPS Est. Cur. Y

5.33

EPS Next Y. (Est.)

5.74

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

32.13

Relative Volume

0.94

Return on Equity vs Sector %

-14.7

Return on Equity vs Industry %

0.6

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.12

EBIT Estimation

-89.8

◆ RPRX Healthcare

$61.73

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

20/20

Pullback

6/25

Volume

7/15

Valuation

5/20

TP/AR

4/10

Options

8/10

RSI

Range 1M

98.5%

Sup Dist

3.7%

🚀

Momentum Growth

Ride accelerating trends

WEAK

Momentum

24/25

Growth

12/30

Estimates

6/20

Inst/Vol

4/15

Options

8/10

EPS Yr

10.3%

EPS NY

7.7%

52W%

99.7%

💎

Long-Term Value

Quality companies, undervalued

N/A

WEAK

🟢 BUY +47.5% upside

Quality

10/30

Valuation

14/30

Growth

10/25

Stability

5/10

LT Trend

4/5

Upside

+47.5%

Quality

MoS

-20%

RPRX — P/E HistoricalBiotechnology

Royalty Pharma plc

Sector: Healthcare

Industry: Biotechnology

Employees: 100

Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States. Its portfolio consists of royalties on approximately 35 marketed therapies and 20 development-stage product candidates that address various therapeutic areas, such as rare disease, oncology, neuroscience, infectious disease, hematology, and diabetes. The company has research and development funding collaboration to advance the development of JNJ-4804, an investigational medicine for autoimmune diseases. The company was founded in 1996 and is based in New York, New York.

RPRX

Latest News

—

Caricamento notizie per RPRX…

stock quote shares RPRX – Royalty Pharma plc Stock Price stock today

news today RPRX – Royalty Pharma plc stock forecast ,stock prediction 2023 2024 2025

marketwatch RPRX – Royalty Pharma plc yahoo finance google finance

stock history RPRX – Royalty Pharma plc invest stock market

stock prices RPRX premarket after hours

ticker RPRX fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: RPRX

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y